Organization Overview
Historical Acquisition Tree
Alternative names
sodium chloride (2017)
Key: Grifols (6) Acquired (13)
coagulation factor ix (Recombinant) (Rixubis) (1 trial)
COVID-19 convalescent plasma (2 trials)
Key: Grifols (1) Acquired (2)
Key: Grifols (0) Acquired (4)
Acquired Immunodeficiency Syndrome (Phase 3)
Acute Kidney Injury (Phase 4)
Acute-On-Chronic Liver Failure (Phase 3)
Afibrinogenemia (Phase 3)
Agammaglobulinemia (Phase 3)
alpha 1-Antitrypsin Deficiency (Phase 3)
Alzheimer Disease (Phase 3)
Amyloidosis (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Antithrombin III Deficiency (Phase 3)
Arterial Occlusive Diseases (Phase 2)
Ascites (Phase 4)
Brain Diseases (Phase 2)
Bronchiectasis (Phase 3)
Common Variable Immunodeficiency (Phase 3)
Communicable Diseases (Phase 2)
Coronavirus Infections (Phase 2)
Crohn Disease (Phase 3)
Cystic Fibrosis (Phase 2)
Deficiency Diseases (Phase 4)
Diabetes Complications (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Neuropathies (Phase 2)
Diphtheria (Phase 1)
Emphysema (Phase 3)
End Stage Liver Disease (Phase 3)
Epilepsy (Phase 3)
Fibrosis (Phase 4)
Hemophilia A (Phase 4)
Hemophilia B (Phase 2)
Hemorrhage (Phase 3)
Hepatic Encephalopathy (Phase 2)
Hepatic Insufficiency (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 3)
Hepatitis B, Chronic (Phase 3)
HIV Infections (Phase 3)
Hypotension (Phase 4)
IgG Deficiency (Phase 2)
Immunologic Deficiency Syndromes (Phase 4)
Infections (Phase 2)
Ischemia (Phase 2)
Liver Cirrhosis (Phase 4)
Liver Failure (Phase 3)
Lung Diseases, Obstructive (Phase 2)
Lupus Erythematosus, Cutaneous (Phase 1)
Lupus Erythematosus, Systemic (Phase 1)
Macular Degeneration (Phase 2)
Motor Neuron Disease (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Muscle Weakness (Phase 4)
Muscular Diseases (Phase 2)
Myasthenia Gravis (Phase 4)
Peripheral Nervous System Diseases (Phase 2)
Poliomyelitis (Phase 3)
Polyneuropathies (Phase 3)
Polyradiculoneuropathy (Phase 3)
Postpoliomyelitis Syndrome (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Pulmonary Emphysema (Phase 3)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Rabies (Phase 1)
Recurrence (Phase 4)
Sclerosis (Phase 2)
Severe Combined Immunodeficiency (Phase 3)
Shock (Phase 3)
Shock, Septic (Phase 3)
Stiff-Person Syndrome (Phase 3)
Stroke (Phase 2)
Syndrome (Phase 3)
Tachycardia (Phase 2)
Tetanus (Phase 4)
Tetany (Phase 4)
Thrombosis (Phase 2)
Venous Thrombosis (Phase 1)
von Willebrand Diseases (Phase 4)
Wiskott-Aldrich Syndrome (Phase 3)